S A Ghafouri, A Ghaniei, M Moghani, N Lotfalizadeh
{"title":"用致病性耐热疫苗接种肉鸡新城疫计划。","authors":"S A Ghafouri, A Ghaniei, M Moghani, N Lotfalizadeh","doi":"10.32592/ARI.2024.79.3.541","DOIUrl":null,"url":null,"abstract":"<p><p>Newcastle disease (ND) is among the most common and deadliest poultry diseases worldwide. Thermostable Newcastle disease virus (NDV) vaccines have been widely used to protect village chickens against ND due to their decreased dependence on cold chains for transport and storage. The NDV4 Heat-Resistant (NDV4HR) vaccine is an apathogenic, heat-resistant, live vaccine that can induce immunity in chickens. In this study, 60 one-day-old Arain local hybrid broilers were divided into three groups of 20. Group A had the usual vaccination program in broiler flocks (seven days old: B1 type by eye drop and ND killed vaccine intramuscularly; 18 and 28 days old: LaSota strain orally). Group B did not receive any vaccine, and group C received the NDV4HR vaccine orally, six times from the first day to the 35<sup>th</sup> day of rearing. All groups were nasally challenged with acute Newcastle virus (genotype VIId) on the 35<sup>th</sup> rearing day. Regarding the hemagglutination inhibition serum antibody titer of the birds after the challenge, group B had the highest (7.12±1.05), and group C (6.37±1.31) had a higher titer than group A (6±1.22). After the challenge with the Newcastle virus, the necropsy findings and clinical symptoms of the disease were almost similar in groups A and C. Group B showed the most signs, with higher casualties than other groups. Regarding weight gain, group C had the highest weight at the end of the study (2204±106). On the second day after the challenge, groups A and B had virus shedding through the trachea and cloaca, while group B shed the virus only through the trachea. Furthermore, on the seventh day after the challenge, group A shed the virus through the cloaca, whereas group B did it through the trachea and the cloaca. On the other hand, there was no virus shedding in group C. This study showed that the NDV4HR vaccine provokes an antibody response that protects the birds against a virulent virus challenge.</p>","PeriodicalId":8311,"journal":{"name":"Archives of Razi Institute","volume":"79 3","pages":"541-548"},"PeriodicalIF":0.0000,"publicationDate":"2024-06-30","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC11682497/pdf/","citationCount":"0","resultStr":"{\"title\":\"Newcastle Disease Vaccination Program in Broilers Using an Apathogenic Heat-Resistant Vaccine.\",\"authors\":\"S A Ghafouri, A Ghaniei, M Moghani, N Lotfalizadeh\",\"doi\":\"10.32592/ARI.2024.79.3.541\",\"DOIUrl\":null,\"url\":null,\"abstract\":\"<p><p>Newcastle disease (ND) is among the most common and deadliest poultry diseases worldwide. Thermostable Newcastle disease virus (NDV) vaccines have been widely used to protect village chickens against ND due to their decreased dependence on cold chains for transport and storage. The NDV4 Heat-Resistant (NDV4HR) vaccine is an apathogenic, heat-resistant, live vaccine that can induce immunity in chickens. In this study, 60 one-day-old Arain local hybrid broilers were divided into three groups of 20. Group A had the usual vaccination program in broiler flocks (seven days old: B1 type by eye drop and ND killed vaccine intramuscularly; 18 and 28 days old: LaSota strain orally). Group B did not receive any vaccine, and group C received the NDV4HR vaccine orally, six times from the first day to the 35<sup>th</sup> day of rearing. All groups were nasally challenged with acute Newcastle virus (genotype VIId) on the 35<sup>th</sup> rearing day. Regarding the hemagglutination inhibition serum antibody titer of the birds after the challenge, group B had the highest (7.12±1.05), and group C (6.37±1.31) had a higher titer than group A (6±1.22). After the challenge with the Newcastle virus, the necropsy findings and clinical symptoms of the disease were almost similar in groups A and C. Group B showed the most signs, with higher casualties than other groups. Regarding weight gain, group C had the highest weight at the end of the study (2204±106). On the second day after the challenge, groups A and B had virus shedding through the trachea and cloaca, while group B shed the virus only through the trachea. Furthermore, on the seventh day after the challenge, group A shed the virus through the cloaca, whereas group B did it through the trachea and the cloaca. On the other hand, there was no virus shedding in group C. This study showed that the NDV4HR vaccine provokes an antibody response that protects the birds against a virulent virus challenge.</p>\",\"PeriodicalId\":8311,\"journal\":{\"name\":\"Archives of Razi Institute\",\"volume\":\"79 3\",\"pages\":\"541-548\"},\"PeriodicalIF\":0.0000,\"publicationDate\":\"2024-06-30\",\"publicationTypes\":\"Journal Article\",\"fieldsOfStudy\":null,\"isOpenAccess\":false,\"openAccessPdf\":\"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC11682497/pdf/\",\"citationCount\":\"0\",\"resultStr\":null,\"platform\":\"Semanticscholar\",\"paperid\":null,\"PeriodicalName\":\"Archives of Razi Institute\",\"FirstCategoryId\":\"1085\",\"ListUrlMain\":\"https://doi.org/10.32592/ARI.2024.79.3.541\",\"RegionNum\":0,\"RegionCategory\":null,\"ArticlePicture\":[],\"TitleCN\":null,\"AbstractTextCN\":null,\"PMCID\":null,\"EPubDate\":\"2024/6/1 0:00:00\",\"PubModel\":\"eCollection\",\"JCR\":\"Q3\",\"JCRName\":\"Veterinary\",\"Score\":null,\"Total\":0}","platform":"Semanticscholar","paperid":null,"PeriodicalName":"Archives of Razi Institute","FirstCategoryId":"1085","ListUrlMain":"https://doi.org/10.32592/ARI.2024.79.3.541","RegionNum":0,"RegionCategory":null,"ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"2024/6/1 0:00:00","PubModel":"eCollection","JCR":"Q3","JCRName":"Veterinary","Score":null,"Total":0}
引用次数: 0
摘要
新城疫(ND)是全球最常见、最致命的家禽疾病之一。由于减少了对冷链运输和储存的依赖,耐热新城疫病毒(NDV)疫苗已被广泛用于保护乡村鸡免受新城疫的侵袭。NDV4 耐热(NDV4HR)疫苗是一种可诱导鸡产生免疫力的无致病性耐热活疫苗。在这项研究中,60 只一天龄的 Arain 本地杂交肉鸡被分为三组,每组 20 只。A 组采用肉鸡群通常的疫苗接种程序(7 日龄:B1 型滴眼疫苗和 ND 株肌肉注射疫苗;18 和 28 日龄:LaSota株口服)。B 组不接种任何疫苗,C 组口服 NDV4HR 疫苗,从育雏第一天到第 35 天共接种六次。在饲养的第 35 天,所有组都接受了急性新城疫病毒(基因型 VIId)的鼻腔挑战。在挑战后的血凝抑制血清抗体滴度方面,B 组最高(7.12±1.05),C 组(6.37±1.31)高于 A 组(6±1.22)。感染新城疫病毒后,A 组和 C 组的剖检结果和临床症状基本相似。在增重方面,C 组在研究结束时体重最高(2204±106)。挑战后第二天,A 组和 B 组通过气管和泄殖腔脱落病毒,而 B 组仅通过气管脱落病毒。此外,在挑战后第七天,A 组通过泄殖腔脱落病毒,而 B 组则通过气管和泄殖腔脱落病毒。这项研究表明,NDV4HR 疫苗可激发抗体反应,保护鸟类免受毒性病毒挑战。
Newcastle Disease Vaccination Program in Broilers Using an Apathogenic Heat-Resistant Vaccine.
Newcastle disease (ND) is among the most common and deadliest poultry diseases worldwide. Thermostable Newcastle disease virus (NDV) vaccines have been widely used to protect village chickens against ND due to their decreased dependence on cold chains for transport and storage. The NDV4 Heat-Resistant (NDV4HR) vaccine is an apathogenic, heat-resistant, live vaccine that can induce immunity in chickens. In this study, 60 one-day-old Arain local hybrid broilers were divided into three groups of 20. Group A had the usual vaccination program in broiler flocks (seven days old: B1 type by eye drop and ND killed vaccine intramuscularly; 18 and 28 days old: LaSota strain orally). Group B did not receive any vaccine, and group C received the NDV4HR vaccine orally, six times from the first day to the 35th day of rearing. All groups were nasally challenged with acute Newcastle virus (genotype VIId) on the 35th rearing day. Regarding the hemagglutination inhibition serum antibody titer of the birds after the challenge, group B had the highest (7.12±1.05), and group C (6.37±1.31) had a higher titer than group A (6±1.22). After the challenge with the Newcastle virus, the necropsy findings and clinical symptoms of the disease were almost similar in groups A and C. Group B showed the most signs, with higher casualties than other groups. Regarding weight gain, group C had the highest weight at the end of the study (2204±106). On the second day after the challenge, groups A and B had virus shedding through the trachea and cloaca, while group B shed the virus only through the trachea. Furthermore, on the seventh day after the challenge, group A shed the virus through the cloaca, whereas group B did it through the trachea and the cloaca. On the other hand, there was no virus shedding in group C. This study showed that the NDV4HR vaccine provokes an antibody response that protects the birds against a virulent virus challenge.